Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Multisarana Intan Eduka Tbk. (MSIE) Price & Performance

UBC Medical Indonesia Tbk.Trade
Multisarana Intan Eduka Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Multisarana Intan Eduka Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp167 (market cap 651.75B, 626.9K 24h volume), while Multisarana Intan Eduka Tbk. trades at Rp99 (market cap 141.62B, 1.03M 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 4.6× Multisarana Intan Eduka Tbk.'s market cap, and Multisarana Intan Eduka Tbk. is more actively traded (1.03M versus 626.9K). Which is the better fit depends on your goals.

LABSMSIE
Market Cap
651.75B141.62B
Volume
626.9K1.03M
Lot
6.27K10.32K
Turnover
103.6M100.24M
Average Price
165.2597.12
Value
103.6M100.24M
Indicative Equilibrium Price
165
Indicative Equilibrium Volume
300

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
MSIE
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Multisarana Intan Eduka Tbk.

PT Multisarana Intan Eduka Tbk (the Company) was established based on Notarial Deed No. 136 ofSitaresmi Puspadewi Subianto, S.H., dated July 30, 2011. The Company started its commercial operations in 2011.

Read more on MSIE